Bayer posted a profit of €2.99 billion in the first half of 2022, compared with a loss of €246 million in the first half of last...
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
Moderna considers Spain to be a key market due to its access to talent, business environment, and the quality of infrastructure, as well as the government's...
Currently, Abi Health has 25 employees and plans to expand the workforce to 60 employees once the financing round is closed, a fact expected this fall....
Asabys, which counts Alantra as a strategic partner, launched the first fund four years ago with an initial target of €60 million and the support of...
Indukern is a national business group created in 1962. Its activity is focused on human and animal health through its two main companies: Kern Pharma, a...
On an international scale, one of the recent projects in which Ship2B Ventures has invested is Fosanis, a German company specializing in digital health. The Teutonic...
Between 2016 and 2021 the investment in the acquisition of medium and high-tech equipment in Aragonese healthcare has exceeded €43 million. Since that date, two linear...
Among the companies selected by Lanzadera there are projects related to the diagnosis of sepsis, pathologies related to muscles and skeletons or those that investigate skin...
The European Union plans to become an important point for clinical trials. The work plan is structured according to the ten ACT EU priority actions and...